Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
 Your new post is loading...
Your new post is loading...
Scoop.it!
The US Food and Drug Administration–approved trial, “A Phase 1, Open-Label, First-in-Human, Feasibility and Safety Study of Human Spinal Cord-Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis, Protocol Number: NS2008-1,” is complete. Our overall objective was to ............. 
No comment yet.
Sign up to comment
Scoop.it!
With an operation to inject stem cells into the spinal cord of an ALS patient on Oct. 2, a team at the University of Michigan completed the first stage of its U.S.
|
Scoop.it!
Two Georgia men are among those willing to risk everything to try to stop ALS.
Scoop.it!
Researchers at Emory University and University of Michigan have begun the Phase II trial of a landmark study to treat patients with Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease) using human neural stem cells.
|
